ABREOS BIOSCIENCES, INC.
2Patents
2Active
2Granted
41Portfolio score
Filing activity: Jun 17, 2016 → Aug 11, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD800912S1 | Point-of-care diagnostic device | General | 68 | Active |
| US11680948B2 | Detection and quantification of natalizumab | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.